CN101073592A - 一种黄芪药材的提取分离方法 - Google Patents
一种黄芪药材的提取分离方法 Download PDFInfo
- Publication number
- CN101073592A CN101073592A CN 200610013742 CN200610013742A CN101073592A CN 101073592 A CN101073592 A CN 101073592A CN 200610013742 CN200610013742 CN 200610013742 CN 200610013742 A CN200610013742 A CN 200610013742A CN 101073592 A CN101073592 A CN 101073592A
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- component
- acquisition time
- eluent
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 235000006533 astragalus Nutrition 0.000 title claims description 17
- 241001061264 Astragalus Species 0.000 title claims description 16
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 title claims description 13
- 238000000605 extraction Methods 0.000 claims abstract description 34
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 192
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 177
- 239000000243 solution Substances 0.000 claims description 104
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 69
- 239000003480 eluent Substances 0.000 claims description 60
- 239000009636 Huang Qi Substances 0.000 claims description 53
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 238000000926 separation method Methods 0.000 claims description 40
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 36
- 239000007864 aqueous solution Substances 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 24
- 238000005516 engineering process Methods 0.000 claims description 23
- 238000004262 preparative liquid chromatography Methods 0.000 claims description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 20
- 239000000741 silica gel Substances 0.000 claims description 20
- 229910002027 silica gel Inorganic materials 0.000 claims description 20
- 229960001866 silicon dioxide Drugs 0.000 claims description 20
- 230000008859 change Effects 0.000 claims description 18
- 238000010828 elution Methods 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 15
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 10
- 239000003208 petroleum Substances 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- NGQQUQKNKAAOJS-UHFFFAOYSA-N (24R)-6alpha,11alpha,16beta,24,25-pentahydroxycycloartan-3-one Natural products CC(CCC(O)C(C)(C)O)C1C(O)CC2(C)C3CC(O)C4C(C)(C)C(=O)CCC45CC35C(O)CC12C NGQQUQKNKAAOJS-UHFFFAOYSA-N 0.000 claims description 9
- WENNXORDXYGDTP-UOUCMYEWSA-N cycloastragenol Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O)C4(C)C)[C@H]4[C@@H](O)C[C@H]3[C@]2(C)C[C@@H]1O WENNXORDXYGDTP-UOUCMYEWSA-N 0.000 claims description 9
- WENNXORDXYGDTP-UHFFFAOYSA-N cyclosiversigenin Natural products O1C(C(C)(O)C)CCC1(C)C1C2(C)CCC34CC4(CCC(O)C4(C)C)C4C(O)CC3C2(C)CC1O WENNXORDXYGDTP-UHFFFAOYSA-N 0.000 claims description 9
- NUNFZNIXYWTZMW-UHFFFAOYSA-N (R)-3',7-Dihydroxy-2',4'-dimethoxyisoflavan Chemical compound COC1=C(O)C(OC)=CC=C1C1CC2=CC=C(O)C=C2OC1 NUNFZNIXYWTZMW-UHFFFAOYSA-N 0.000 claims description 6
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 claims description 4
- NNYKOYIGBZQYAI-UHFFFAOYSA-N Cyclocanthogenin Natural products C1CC(O)C(C)(C)C2C31CC13CCC3(C)C(C(CCC(O)C(C)(C)O)C)C(O)CC3(C)C1CC2O NNYKOYIGBZQYAI-UHFFFAOYSA-N 0.000 claims description 3
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 claims description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 33
- 239000000463 material Substances 0.000 abstract description 3
- 238000007877 drug screening Methods 0.000 abstract description 2
- 229940107666 astragalus root Drugs 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 2
- 210000000582 semen Anatomy 0.000 description 35
- 241000628997 Flos Species 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 9
- 238000001819 mass spectrum Methods 0.000 description 8
- 238000011160 research Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000045403 Astragalus propinquus Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 241000209020 Cornus Species 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- -1 electuary Substances 0.000 description 2
- 238000000105 evaporative light scattering detection Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000563984 Ampelopsis Species 0.000 description 1
- 241000746375 Andrographis Species 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 241000489492 Arisaema Species 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000959626 Calvatia Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241001649190 Campsis Species 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 239000008589 Cortex Fraxini Substances 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 241000217407 Margaritifera Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 241001250596 Pleione Species 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000044425 Quisqualis indica Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 239000004870 Styrax Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241001643642 Viticis Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VUKCFTVODWLXPK-UHFFFAOYSA-N andinermal C Natural products O1C2=CC(OC)=CC(O)=C2C(C=O)=C1C1=CC=C(O)C(O)=C1OC VUKCFTVODWLXPK-UHFFFAOYSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000009670 cang er zi wan Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 239000009969 fructus bruceae Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940056582 human hair preparation Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000009806 pulsatillae Substances 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
黄芪组分 | 已鉴定的化合物 |
fr.51fr.55fr.81fr.82fr.83fr.84fr.85fr.87 | Cycloasgenin B;cycloastragenol;Coumestrol;3′,7-Dihydroxy-2′,4′-dimethoxyisoflavan(±form);4′-Me ether,7-O-(6-O-malonyl--D-glucopyranoside)4′-Me ether,7-O-(6-O-malonyl--D-glucopyranoside)Cycloasgenin C;Cycloasgenin B;calycosinCycloasgenin B;cycloastragenol;FormononetincycloastragenolCoumestrol |
组分 | 保留时间(分) | [M-H] | 最大UV | 化合物 | 结构式 | 备注 |
fr.81 | 3.768 | 531 | 198 | 4′-Me ether,7-O-(6-O-malonyl-β-D-glucopyranoside) | C25H24O13 | DNP |
fr.82 | 3.780 | 531 | 198 | 4′-Me ether,7-O-(6-O-malonyl-β-D-glucopyranoside) | C25H24O13 | DNP |
fr.83 | 3.791 | 491 | 198,280 | Cycloasgenin C | C30H52O5 | DNP |
7.330 | 505 | 200,220,248,260,290 | Cycloasgenin B | C30H50O6 | DNP | |
8.3 | 283 | 198,218,258,290 | calycosin | C16H12O5 | DNP | |
fr.84 | 7.3 | 505 | 200,220,248,260,290 | Cycloasgenin B | C30H50O6 | DNP |
11.5 | 489 | 198,248,264,306 | cycloastragenol | C30H50O5 | DNP | |
12.1 | 267 | 196,250,308 | Formononetin | C16H12O4 | DNP | |
fr.85 | 11.5 | 489 | 198,248,264,306 | cycloastragenol | C30H50O5 | 文献1 |
fr.87 | 19.4 | 267 | 194,250,308 | Coumestrol | C15H8O5 | DNP |
fr.51 | 3.3 | 243 | 202,262 | |||
9.8 | 505 | 198,220,250,258,290 | Cycloasgenin B | C30H50O6 | 文献1 | |
11.9 | 489 | 198,230,250,306 | cycloastragenol | C30H50O5 | 文献1 |
fr.55 | 16.7 | 267 | 194,250,308 | Coumestrol | C15H8O5 | 文献1 |
17.5 | 301 | 204,280 | 3′,7-Dihydroxy-2′,4′-dimethoxyisoflavan(±form) | C17H18O5 | DNP |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100137423A CN101073592B (zh) | 2006-05-18 | 2006-05-18 | 一种黄芪药材的提取分离方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100137423A CN101073592B (zh) | 2006-05-18 | 2006-05-18 | 一种黄芪药材的提取分离方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101073592A true CN101073592A (zh) | 2007-11-21 |
CN101073592B CN101073592B (zh) | 2011-08-10 |
Family
ID=38974970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100137423A Expired - Fee Related CN101073592B (zh) | 2006-05-18 | 2006-05-18 | 一种黄芪药材的提取分离方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101073592B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110053872A1 (en) * | 2009-01-16 | 2011-03-03 | Guangzhou Consun Medicine R & D Co., Ltd. | Pharmaceutical Composition For Preventing And Treating Diabetic Nephropathy And The Preparation Method Thereof |
CN102125599A (zh) * | 2011-03-13 | 2011-07-20 | 浙江大学 | 一种黄芪有效组分制备方法与用途 |
CN102133262A (zh) * | 2011-03-13 | 2011-07-27 | 浙江大学 | 具心肌保护作用的黄芪有效组分制备方法与用途 |
CN102353738A (zh) * | 2011-08-26 | 2012-02-15 | 兰州大学 | 豆科黄芪属多年生草本植物中一种致毒物检测方法 |
CN103880910A (zh) * | 2014-03-19 | 2014-06-25 | 西南交通大学 | 一种环黄芪醇的制备方法及其用途 |
CN106324167A (zh) * | 2015-07-06 | 2017-01-11 | 天津天士力现代中药资源有限公司 | 一种uplc测定黄芪提取物中黄酮类成分的方法 |
CN106483214A (zh) * | 2016-09-27 | 2017-03-08 | 华润三九医药股份有限公司 | 达原饮组合物的质量控制方法 |
CN107041881A (zh) * | 2017-02-22 | 2017-08-15 | 广东医科大学 | 毛蕊异黄酮在制备抗轮状病毒药物中的应用 |
CN107311705A (zh) * | 2017-07-13 | 2017-11-03 | 聊城大学 | 一种马勃活性成分梯度分离与综合利用方法 |
CN107782833A (zh) * | 2016-08-24 | 2018-03-09 | 江苏康缘药业股份有限公司 | 一种确定芪白平肺颗粒指纹图谱的方法及其指纹图谱 |
CN109324138A (zh) * | 2018-12-14 | 2019-02-12 | 江苏七0七天然制药有限公司 | 一种如意金黄散指纹图谱建立方法 |
CN109833377A (zh) * | 2019-03-27 | 2019-06-04 | 长沙理工大学 | 一种油茶蒲提取物及其制备方法和应用 |
CN113933438A (zh) * | 2021-11-11 | 2022-01-14 | 威海华洋药业有限公司 | 一种紫芪克咳口服液的含量测定方法及制备方法 |
CN115479995A (zh) * | 2021-05-31 | 2022-12-16 | 上海长征医院 | 一种升陷汤提取工艺的优选方法 |
CN116338073A (zh) * | 2023-05-19 | 2023-06-27 | 山东省食品药品检验研究院 | 一种芪蛭益肾胶囊的薄层色谱检测方法 |
CN117250300A (zh) * | 2023-11-17 | 2023-12-19 | 江西中医药大学 | 藏药二十五味大汤丸中多成分的检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1279052C (zh) * | 2004-03-11 | 2006-10-11 | 南开大学 | 从黄芪中提取黄芪总黄酮和总甙的方法 |
-
2006
- 2006-05-18 CN CN2006100137423A patent/CN101073592B/zh not_active Expired - Fee Related
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110053872A1 (en) * | 2009-01-16 | 2011-03-03 | Guangzhou Consun Medicine R & D Co., Ltd. | Pharmaceutical Composition For Preventing And Treating Diabetic Nephropathy And The Preparation Method Thereof |
CN102125599A (zh) * | 2011-03-13 | 2011-07-20 | 浙江大学 | 一种黄芪有效组分制备方法与用途 |
CN102133262A (zh) * | 2011-03-13 | 2011-07-27 | 浙江大学 | 具心肌保护作用的黄芪有效组分制备方法与用途 |
CN102125599B (zh) * | 2011-03-13 | 2012-12-05 | 浙江大学 | 一种黄芪有效组分制备方法与用途 |
CN102353738A (zh) * | 2011-08-26 | 2012-02-15 | 兰州大学 | 豆科黄芪属多年生草本植物中一种致毒物检测方法 |
CN103880910B (zh) * | 2014-03-19 | 2015-11-25 | 西南交通大学 | 一种环黄芪醇的制备方法及其用途 |
CN103880910A (zh) * | 2014-03-19 | 2014-06-25 | 西南交通大学 | 一种环黄芪醇的制备方法及其用途 |
CN106324167A (zh) * | 2015-07-06 | 2017-01-11 | 天津天士力现代中药资源有限公司 | 一种uplc测定黄芪提取物中黄酮类成分的方法 |
CN106324167B (zh) * | 2015-07-06 | 2020-04-03 | 天津天士力现代中药资源有限公司 | 一种uplc测定黄芪提取物中黄酮类成分的方法 |
CN107782833A (zh) * | 2016-08-24 | 2018-03-09 | 江苏康缘药业股份有限公司 | 一种确定芪白平肺颗粒指纹图谱的方法及其指纹图谱 |
CN106483214A (zh) * | 2016-09-27 | 2017-03-08 | 华润三九医药股份有限公司 | 达原饮组合物的质量控制方法 |
CN107041881A (zh) * | 2017-02-22 | 2017-08-15 | 广东医科大学 | 毛蕊异黄酮在制备抗轮状病毒药物中的应用 |
CN107041881B (zh) * | 2017-02-22 | 2021-02-09 | 广东医科大学 | 毛蕊异黄酮在制备抗轮状病毒药物中的应用 |
CN107311705B (zh) * | 2017-07-13 | 2021-02-05 | 聊城大学 | 一种马勃活性成分梯度分离与综合利用方法 |
CN107311705A (zh) * | 2017-07-13 | 2017-11-03 | 聊城大学 | 一种马勃活性成分梯度分离与综合利用方法 |
CN109324138A (zh) * | 2018-12-14 | 2019-02-12 | 江苏七0七天然制药有限公司 | 一种如意金黄散指纹图谱建立方法 |
CN109324138B (zh) * | 2018-12-14 | 2021-07-13 | 江苏七0七天然制药有限公司 | 一种如意金黄散指纹图谱建立方法 |
CN109833377A (zh) * | 2019-03-27 | 2019-06-04 | 长沙理工大学 | 一种油茶蒲提取物及其制备方法和应用 |
CN109833377B (zh) * | 2019-03-27 | 2021-06-18 | 长沙理工大学 | 一种油茶蒲提取物及其制备方法和应用 |
CN115479995A (zh) * | 2021-05-31 | 2022-12-16 | 上海长征医院 | 一种升陷汤提取工艺的优选方法 |
CN113933438A (zh) * | 2021-11-11 | 2022-01-14 | 威海华洋药业有限公司 | 一种紫芪克咳口服液的含量测定方法及制备方法 |
CN113933438B (zh) * | 2021-11-11 | 2023-11-10 | 威海华洋药业有限公司 | 一种紫芪克咳口服液的含量测定方法及制备方法 |
CN116338073A (zh) * | 2023-05-19 | 2023-06-27 | 山东省食品药品检验研究院 | 一种芪蛭益肾胶囊的薄层色谱检测方法 |
CN116338073B (zh) * | 2023-05-19 | 2023-07-25 | 山东省食品药品检验研究院 | 一种芪蛭益肾胶囊的薄层色谱检测方法 |
CN117250300A (zh) * | 2023-11-17 | 2023-12-19 | 江西中医药大学 | 藏药二十五味大汤丸中多成分的检测方法 |
CN117250300B (zh) * | 2023-11-17 | 2024-02-20 | 江西中医药大学 | 藏药二十五味大汤丸中多成分的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101073592B (zh) | 2011-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101073592A (zh) | 一种黄芪药材的提取分离方法 | |
CN101073587A (zh) | 一种柴胡药材的提取分离方法 | |
CN1903250A (zh) | 一种丹参药材的提取分离方法 | |
CN101073606A (zh) | 一种白芍药材的提取分离方法 | |
CN101073623A (zh) | 一种蒲黄药材的提取分离方法 | |
CN1903239A (zh) | 一种川芎药材的提取分离方法 | |
CN1903241A (zh) | 一种三七药材的提取分离方法 | |
CN1806846A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN101810793B (zh) | 玉米须黄酮在制备治疗高血脂症药物中的应用 | |
WO2009117953A1 (zh) | 一种具有抗抑郁、抗焦虑作用的药物组合物及其制备方法 | |
CN1765390A (zh) | 一种治疗肺心病的中药 | |
CN100340283C (zh) | 用于皮炎治疗的化妆水 | |
CN100335115C (zh) | 用于皮炎治疗的软膏 | |
CN101214270B (zh) | 刺五加有效部位的提取物、其制备方法、其应用 | |
CN1785284A (zh) | 一种含有何首乌的药物组合物 | |
CN104288245B (zh) | 抗衰老和增强体质的药物组合物及其制备方法和检测方法 | |
CN1927230A (zh) | 一种中药超声提取树脂纯化工艺 | |
CN1479625A (zh) | 治疗免疫疾病的草药药物组合物 | |
CN1876089A (zh) | 一种治疗肾气虚证的药物组合物及其制备方法 | |
CN1903279A (zh) | 一种枳壳药材的提取分离方法 | |
CN1903259A (zh) | 一种丹皮药材的提取分离方法 | |
CN106266935A (zh) | 一种中西药复方戒毒药及其制备方法 | |
CN100502887C (zh) | 一种黄芪多糖口含片 | |
CN100336544C (zh) | 一种具有健肤美容作用的中药组合物及其制备方法 | |
CN1313130C (zh) | 一种治疗胃痛的药物组合物、制备方法及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20210518 |